Diligence memo · auto-generated · as of July 2, 2026

MedRhythms, Inc.

MedRhythms, Inc. looks under-valued against its niche peers and is active on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

MedRhythms, Inc. operates in Other Technology, based in PORTLAND.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

MedRhythms, Inc. has raised $59M in disclosed capital across 7 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $21M on 2021-07-16.

Most recent recorded round closed around 2026-02-13.

Valuation (modeled)modeled

Provath models MedRhythms, Inc. at approximately $14M (range $8.0M–$18M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.14× the median modeled value of Series B Other Technology companies in 2025–2027 (194 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 13 months.

Last raise 5 mo ago; this sector typically re-raises about every 13 months.

Raising on or ahead of the sector's normal rhythm.

The last round stepped up 1.1× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 94% of Other Technology peers (21302 compared).

Modeled value ranks above 29% of those peers.

Closest niche peers: Proscia Inc., Creditly Corp., Enbalg Group Corp, Lumana Inc., ProrataAI, Inc..

Peoplefiled

15 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.